Daniel Shae

Daniel Shae

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4393762
-
person_outline Daniel Shae's MOST POPULAR ARTICLES
1-) Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapyD Shae, KW Becker, P Christov, DS Yun, AKR Lytton-Jean, S Sevimli, ...Nature nanotechnology 14 (3), 269-278, 20195312019
2-) Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastomaL Wang-Bishop, M Wehbe, D Shae, J James, BC Hacker, K Garland, ...Journal for immunotherapy of cancer 8 (1), 20201312020
3-) Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccinesD Shae, JJ Baljon, M Wehbe, PP Christov, KW Becker, A Kumar, ...ACS nano 14 (8), 9904-9916, 20201262020
4-) Poly (propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccinesF Qiu, KW Becker, FC Knight, JJ Baljon, S Sevimli, D Shae, P Gilchuk, ...Biomaterials 182, 82-91, 2018942018
5-) Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administrationM Wehbe, L Wang-Bishop, KW Becker, D Shae, JJ Baljon, X He, ...Journal of Controlled Release 330, 1118-1129, 2021882021